Poly(amidoamine) Dendrimers Increase Antifungal Activity of Clotrimazole
Clotrimazole (CLO) is a local imidazolic antifungal agent. A major problem associated with the successful formulation of effective dosage forms containing CLO is its poor aqueous solubility, which presents a hindrance for the local availability of CLO and limits the effective antifungal therapy. In...
Gespeichert in:
Veröffentlicht in: | Biological & pharmaceutical bulletin 2011/07/01, Vol.34(7), pp.1129-1133 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1133 |
---|---|
container_issue | 7 |
container_start_page | 1129 |
container_title | Biological & pharmaceutical bulletin |
container_volume | 34 |
creator | Winnicka, Katarzyna Sosnowska, Katarzyna Wieczorek, Piotr Sacha, Pawel Tomasz Tryniszewska, Elzbieta |
description | Clotrimazole (CLO) is a local imidazolic antifungal agent. A major problem associated with the successful formulation of effective dosage forms containing CLO is its poor aqueous solubility, which presents a hindrance for the local availability of CLO and limits the effective antifungal therapy. In the present study, the effects of various concentrations of poly(amidoamine) (PAMAM) dendrimers generation 2 (G2) and generation 3 (G3) with amine (PAMAM-NH2) or hydroxyl surface groups (PAMAM-OH) on aqueous solubility and antifungal activity of CLO were studied. The obtained results showed that all tested PAMAM dendrimers improved the solubility of CLO and the more potent were PAMAM-NH2 dendrimers. The increase in solubility of CLO was highest at dendrimer concentration of 10 mg/ml. Microbiology studies indicated that only PAMAM-NH2 dendrimers significantly increased the antifungal activity of CLO (a 4—32-fold increase in the antifungal activity compared to pure CLO) and the most potent was dendrimer PAMAM-NH2 G2. These observations indicate that PAMAM dendrimers might be considered as potential carriers of CLO and provide further impetus to evaluate these polymers for use in basic drug delivery studies and to design semisolid dosage forms based on dendrimers with antimicrobial drugs, like CLO. |
doi_str_mv | 10.1248/bpb.34.1129 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_874486570</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>874486570</sourcerecordid><originalsourceid>FETCH-LOGICAL-c557t-e884fb095e86440403f1be7cbb474f6fbdd37fad2051b8e6b5f4862ec31ed5f23</originalsourceid><addsrcrecordid>eNpd0EtrGzEUBWBRUmrH7Sr7MJBFEsq4eo7kXYyTNAFDu2jXQtJcOWPGI0eaKbi_vjJ-LLq5WujTQfcgdEXwlFCuvtmtnTI-JYTOPqAxYVyWghJxgcZ4RlRZEaFG6DKlNcZYYso-oRElkmJMqzF6-Rna3Z3ZNHXIo4P74hG6OjYbiKl47VwEk6CYd33jh25l2mLu-uZP0--K4ItFG_pMzd_Qwmf00Zs2wZfjOUG_n59-LV7K5Y_vr4v5snRCyL4Epbi3eCZAVZxjjpknFqSzlkvuK2_rmklvaooFsQoqKzxXFQXHCNTCUzZBt4fcbQzvA6Reb5rkoG1NB2FIWkmeHwiJs7z5T67DELv8OU04nzGFCa6y-npQLoaUIni93a8Ud5pgve9X534143rfb9bXx8zBbqA-21OhGTwcwDr1ZgVnYGLfuBZOYfIw9pnnK_dmooaO_QPoK4ya</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1449380106</pqid></control><display><type>article</type><title>Poly(amidoamine) Dendrimers Increase Antifungal Activity of Clotrimazole</title><source>J-STAGE Free</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Winnicka, Katarzyna ; Sosnowska, Katarzyna ; Wieczorek, Piotr ; Sacha, Pawel Tomasz ; Tryniszewska, Elzbieta</creator><creatorcontrib>Winnicka, Katarzyna ; Sosnowska, Katarzyna ; Wieczorek, Piotr ; Sacha, Pawel Tomasz ; Tryniszewska, Elzbieta</creatorcontrib><description>Clotrimazole (CLO) is a local imidazolic antifungal agent. A major problem associated with the successful formulation of effective dosage forms containing CLO is its poor aqueous solubility, which presents a hindrance for the local availability of CLO and limits the effective antifungal therapy. In the present study, the effects of various concentrations of poly(amidoamine) (PAMAM) dendrimers generation 2 (G2) and generation 3 (G3) with amine (PAMAM-NH2) or hydroxyl surface groups (PAMAM-OH) on aqueous solubility and antifungal activity of CLO were studied. The obtained results showed that all tested PAMAM dendrimers improved the solubility of CLO and the more potent were PAMAM-NH2 dendrimers. The increase in solubility of CLO was highest at dendrimer concentration of 10 mg/ml. Microbiology studies indicated that only PAMAM-NH2 dendrimers significantly increased the antifungal activity of CLO (a 4—32-fold increase in the antifungal activity compared to pure CLO) and the most potent was dendrimer PAMAM-NH2 G2. These observations indicate that PAMAM dendrimers might be considered as potential carriers of CLO and provide further impetus to evaluate these polymers for use in basic drug delivery studies and to design semisolid dosage forms based on dendrimers with antimicrobial drugs, like CLO.</description><identifier>ISSN: 0918-6158</identifier><identifier>EISSN: 1347-5215</identifier><identifier>DOI: 10.1248/bpb.34.1129</identifier><identifier>PMID: 21720026</identifier><language>eng</language><publisher>Japan: The Pharmaceutical Society of Japan</publisher><subject>antifungal activity ; Antifungal Agents - pharmacology ; aqueous solubility ; Candida - classification ; Candida - drug effects ; clotrimazole ; Clotrimazole - pharmacology ; Dendrimers - pharmacology ; Microbial Sensitivity Tests ; poly(amidoamine) dendrimer ; Solubility</subject><ispartof>Biological and Pharmaceutical Bulletin, 2011/07/01, Vol.34(7), pp.1129-1133</ispartof><rights>2011 The Pharmaceutical Society of Japan</rights><rights>Copyright Japan Science and Technology Agency 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c557t-e884fb095e86440403f1be7cbb474f6fbdd37fad2051b8e6b5f4862ec31ed5f23</citedby><cites>FETCH-LOGICAL-c557t-e884fb095e86440403f1be7cbb474f6fbdd37fad2051b8e6b5f4862ec31ed5f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21720026$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Winnicka, Katarzyna</creatorcontrib><creatorcontrib>Sosnowska, Katarzyna</creatorcontrib><creatorcontrib>Wieczorek, Piotr</creatorcontrib><creatorcontrib>Sacha, Pawel Tomasz</creatorcontrib><creatorcontrib>Tryniszewska, Elzbieta</creatorcontrib><title>Poly(amidoamine) Dendrimers Increase Antifungal Activity of Clotrimazole</title><title>Biological & pharmaceutical bulletin</title><addtitle>Biol Pharm Bull</addtitle><description>Clotrimazole (CLO) is a local imidazolic antifungal agent. A major problem associated with the successful formulation of effective dosage forms containing CLO is its poor aqueous solubility, which presents a hindrance for the local availability of CLO and limits the effective antifungal therapy. In the present study, the effects of various concentrations of poly(amidoamine) (PAMAM) dendrimers generation 2 (G2) and generation 3 (G3) with amine (PAMAM-NH2) or hydroxyl surface groups (PAMAM-OH) on aqueous solubility and antifungal activity of CLO were studied. The obtained results showed that all tested PAMAM dendrimers improved the solubility of CLO and the more potent were PAMAM-NH2 dendrimers. The increase in solubility of CLO was highest at dendrimer concentration of 10 mg/ml. Microbiology studies indicated that only PAMAM-NH2 dendrimers significantly increased the antifungal activity of CLO (a 4—32-fold increase in the antifungal activity compared to pure CLO) and the most potent was dendrimer PAMAM-NH2 G2. These observations indicate that PAMAM dendrimers might be considered as potential carriers of CLO and provide further impetus to evaluate these polymers for use in basic drug delivery studies and to design semisolid dosage forms based on dendrimers with antimicrobial drugs, like CLO.</description><subject>antifungal activity</subject><subject>Antifungal Agents - pharmacology</subject><subject>aqueous solubility</subject><subject>Candida - classification</subject><subject>Candida - drug effects</subject><subject>clotrimazole</subject><subject>Clotrimazole - pharmacology</subject><subject>Dendrimers - pharmacology</subject><subject>Microbial Sensitivity Tests</subject><subject>poly(amidoamine) dendrimer</subject><subject>Solubility</subject><issn>0918-6158</issn><issn>1347-5215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpd0EtrGzEUBWBRUmrH7Sr7MJBFEsq4eo7kXYyTNAFDu2jXQtJcOWPGI0eaKbi_vjJ-LLq5WujTQfcgdEXwlFCuvtmtnTI-JYTOPqAxYVyWghJxgcZ4RlRZEaFG6DKlNcZYYso-oRElkmJMqzF6-Rna3Z3ZNHXIo4P74hG6OjYbiKl47VwEk6CYd33jh25l2mLu-uZP0--K4ItFG_pMzd_Qwmf00Zs2wZfjOUG_n59-LV7K5Y_vr4v5snRCyL4Epbi3eCZAVZxjjpknFqSzlkvuK2_rmklvaooFsQoqKzxXFQXHCNTCUzZBt4fcbQzvA6Reb5rkoG1NB2FIWkmeHwiJs7z5T67DELv8OU04nzGFCa6y-npQLoaUIni93a8Ud5pgve9X534143rfb9bXx8zBbqA-21OhGTwcwDr1ZgVnYGLfuBZOYfIw9pnnK_dmooaO_QPoK4ya</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>Winnicka, Katarzyna</creator><creator>Sosnowska, Katarzyna</creator><creator>Wieczorek, Piotr</creator><creator>Sacha, Pawel Tomasz</creator><creator>Tryniszewska, Elzbieta</creator><general>The Pharmaceutical Society of Japan</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20110701</creationdate><title>Poly(amidoamine) Dendrimers Increase Antifungal Activity of Clotrimazole</title><author>Winnicka, Katarzyna ; Sosnowska, Katarzyna ; Wieczorek, Piotr ; Sacha, Pawel Tomasz ; Tryniszewska, Elzbieta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c557t-e884fb095e86440403f1be7cbb474f6fbdd37fad2051b8e6b5f4862ec31ed5f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>antifungal activity</topic><topic>Antifungal Agents - pharmacology</topic><topic>aqueous solubility</topic><topic>Candida - classification</topic><topic>Candida - drug effects</topic><topic>clotrimazole</topic><topic>Clotrimazole - pharmacology</topic><topic>Dendrimers - pharmacology</topic><topic>Microbial Sensitivity Tests</topic><topic>poly(amidoamine) dendrimer</topic><topic>Solubility</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Winnicka, Katarzyna</creatorcontrib><creatorcontrib>Sosnowska, Katarzyna</creatorcontrib><creatorcontrib>Wieczorek, Piotr</creatorcontrib><creatorcontrib>Sacha, Pawel Tomasz</creatorcontrib><creatorcontrib>Tryniszewska, Elzbieta</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biological & pharmaceutical bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Winnicka, Katarzyna</au><au>Sosnowska, Katarzyna</au><au>Wieczorek, Piotr</au><au>Sacha, Pawel Tomasz</au><au>Tryniszewska, Elzbieta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Poly(amidoamine) Dendrimers Increase Antifungal Activity of Clotrimazole</atitle><jtitle>Biological & pharmaceutical bulletin</jtitle><addtitle>Biol Pharm Bull</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>34</volume><issue>7</issue><spage>1129</spage><epage>1133</epage><pages>1129-1133</pages><issn>0918-6158</issn><eissn>1347-5215</eissn><abstract>Clotrimazole (CLO) is a local imidazolic antifungal agent. A major problem associated with the successful formulation of effective dosage forms containing CLO is its poor aqueous solubility, which presents a hindrance for the local availability of CLO and limits the effective antifungal therapy. In the present study, the effects of various concentrations of poly(amidoamine) (PAMAM) dendrimers generation 2 (G2) and generation 3 (G3) with amine (PAMAM-NH2) or hydroxyl surface groups (PAMAM-OH) on aqueous solubility and antifungal activity of CLO were studied. The obtained results showed that all tested PAMAM dendrimers improved the solubility of CLO and the more potent were PAMAM-NH2 dendrimers. The increase in solubility of CLO was highest at dendrimer concentration of 10 mg/ml. Microbiology studies indicated that only PAMAM-NH2 dendrimers significantly increased the antifungal activity of CLO (a 4—32-fold increase in the antifungal activity compared to pure CLO) and the most potent was dendrimer PAMAM-NH2 G2. These observations indicate that PAMAM dendrimers might be considered as potential carriers of CLO and provide further impetus to evaluate these polymers for use in basic drug delivery studies and to design semisolid dosage forms based on dendrimers with antimicrobial drugs, like CLO.</abstract><cop>Japan</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>21720026</pmid><doi>10.1248/bpb.34.1129</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0918-6158 |
ispartof | Biological and Pharmaceutical Bulletin, 2011/07/01, Vol.34(7), pp.1129-1133 |
issn | 0918-6158 1347-5215 |
language | eng |
recordid | cdi_proquest_miscellaneous_874486570 |
source | J-STAGE Free; MEDLINE; EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry |
subjects | antifungal activity Antifungal Agents - pharmacology aqueous solubility Candida - classification Candida - drug effects clotrimazole Clotrimazole - pharmacology Dendrimers - pharmacology Microbial Sensitivity Tests poly(amidoamine) dendrimer Solubility |
title | Poly(amidoamine) Dendrimers Increase Antifungal Activity of Clotrimazole |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T12%3A33%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Poly(amidoamine)%20Dendrimers%20Increase%20Antifungal%20Activity%20of%20Clotrimazole&rft.jtitle=Biological%20&%20pharmaceutical%20bulletin&rft.au=Winnicka,%20Katarzyna&rft.date=2011-07-01&rft.volume=34&rft.issue=7&rft.spage=1129&rft.epage=1133&rft.pages=1129-1133&rft.issn=0918-6158&rft.eissn=1347-5215&rft_id=info:doi/10.1248/bpb.34.1129&rft_dat=%3Cproquest_cross%3E874486570%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1449380106&rft_id=info:pmid/21720026&rfr_iscdi=true |